GLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department presentation in adults with schizophrenia and type 2 diabetes in the USA: an observational cohort study using electronic health records data
GLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department presentation in adults with schizophrenia and type 2 diabetes in the USA: an observational cohort study using electronic health records data. // The Lancet Psychiatry. – URL: https://www.sciencedirect.com/science/article/pii/S2215036626002762?dgcid=rss_sd_all
GLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department presentation in adults with schizophrenia and type 2 diabetes in the USA: an observational cohort study using electronic health records data. The Lancet Psychiatry. https://www.sciencedirect.com/science/article/pii/S2215036626002762?dgcid=rss_sd_all
“GLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department presentation in adults with schizophrenia and type 2 diabetes in the USA: an observational cohort study using electronic health records data.” The Lancet Psychiatry.
@article{article69068,
title = {GLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department presentation in adults with schizophrenia and type 2 diabetes in the USA: an observational cohort study using electronic health records data},
journal = {The Lancet Psychiatry},
url = {https://www.sciencedirect.com/science/article/pii/S2215036626002762?dgcid=rss_sd_all}
}